Planta Med
DOI: 10.1055/a-2294-6922
Original Papers

Cardioprotective Effects of Aloysia polystachya Essential Oil on a Rat Model with Multiple Cardiovascular Risk Factors

Karyne Garcia Tafarelo Moreno
1   Laboratory of Cardiovascular Pharmacology (LaFAC), Faculty of Health Sciences, Federal University of Grande Dourados, Dourados, MS, Brazil
,
Aline Aparecida Macedo Marques
1   Laboratory of Cardiovascular Pharmacology (LaFAC), Faculty of Health Sciences, Federal University of Grande Dourados, Dourados, MS, Brazil
,
Gabriela Pereira da Silva
1   Laboratory of Cardiovascular Pharmacology (LaFAC), Faculty of Health Sciences, Federal University of Grande Dourados, Dourados, MS, Brazil
,
Luana Ale Bertoncelo
1   Laboratory of Cardiovascular Pharmacology (LaFAC), Faculty of Health Sciences, Federal University of Grande Dourados, Dourados, MS, Brazil
,
Luciane Barbosa Pessoal
1   Laboratory of Cardiovascular Pharmacology (LaFAC), Faculty of Health Sciences, Federal University of Grande Dourados, Dourados, MS, Brazil
,
Larissa Dantas Gonçalves
1   Laboratory of Cardiovascular Pharmacology (LaFAC), Faculty of Health Sciences, Federal University of Grande Dourados, Dourados, MS, Brazil
,
Ariany Carvalho dos Santos
2   Laboratory of Histopathology, Faculty of Health Sciences, Federal University of Grande Dourados, Dourados, MS, Brazil
,
Roosevelt Isaías Carvalho Souza
2   Laboratory of Histopathology, Faculty of Health Sciences, Federal University of Grande Dourados, Dourados, MS, Brazil
,
Denise Brentan Silva
3   Laboratory of Natural Products and Mass Spectrometry (LAPNEM), Federal University of Mato Grosso do Sul, Campo Grande, MS, Brazil
,
1   Laboratory of Cardiovascular Pharmacology (LaFAC), Faculty of Health Sciences, Federal University of Grande Dourados, Dourados, MS, Brazil
› Author Affiliations
Supported by: Conselho Nacional de Desenvolvimento Científico e Tecnológico 305742/2022-1
Supported by: Fundação de Apoio ao Desenvolvimento do Ensino, Ciência e Tecnologia do Estado de Mato Grosso do Sul 83/013.186/2023
Supported by: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Abstract

Traditional medicine is a frequently utilized method to treat cardiovascular disease and its primary risk factors, including hypertension and dyslipidemia. Aloysia polystachya is a species that is commonly employed to treat various pathological conditions, and it has already been identified as having some cardioprotective effects. This study aimed to investigate the protective effects of the essential oil extracted from the leaves of A. polystachya in a rat model that simulates multiple cardiovascular risk factors. We evaluate the acute toxicity, as well as the cardioprotective effects, by giving different doses of A. polystachya essential oil (1.47 mg/kg, 4.40 mg/kg, and 13.20 mg/kg) over a period of 42 days. The control group was treated with rosuvastatin (5 mg/kg). At the end of the treatments, the renal function, electrocardiography, blood pressure, vascular reactivity, serum biochemical profile, and organ histopathology were evaluated. The main compounds identified in the essential oil of A. polystachya using gas chromatography coupled with mass spectrometry were beta-myrcene (1.08%), limonene (40.13%), and carvone (56.47%). The essential oil of A. polystachya not only lacks acute toxicity but also mitigates the reduction in the excretion of sodium, chloride, and creatinine in urine. Furthermore, it reduces electrocardiographic abnormalities and decreases blood pressure levels. Moreover, this treatment prevents an elevation in markers of inflammation and oxidative stress in the bloodstream. Our findings indicate significant cardioprotective effects of the essential oil of A. polystachya against multiple risk factors for cardiovascular diseases in hypertensive rats.



Publication History

Received: 25 September 2023

Accepted after revision: 19 March 2024

Article published online:
17 April 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Roth GA, Abate D, Abate KH. et al. Global regional and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017. a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018; 392: 1736-1788 DOI: 10.1016/S0140-6736(18)32203-7.
  • 2 Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, Himmelfarb CD, Khera A, Lloyd-Jones D, McEvoy JW, Michos ED, Miedema MD, Muñoz D, Smith SC, Virani SS, Williams KA, Yeboah J. Ziaeian B. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease. J Am Coll Cardiol 2019; 74: e177 DOI: 10.1016/j.jacc.2019.03.010.
  • 3 Bays HE, Taub PR, Epstein E, Michos ED, Ferraro RA, Bailey AL, Kelli HM, Ferdinand KC, Echols MR, Weintraub H, Bostrom J, Johnson HM, Hoppe KK, Shapiro MD, German CA, Virani SS, Hussain A, Ballantyne M, Agha AM, Toth PP. Ten things to know about ten cardiovascular disease risk factors. Am J Prev Cardiol 2021; 5: 100149 DOI: 10.1016/j.ajpc.2021.100149.
  • 4 World Health Organization. WHO global report on traditional and complementary medicine 2019. World Health Organization, 2019.
  • 5 Shaito A, Thuan DTB, Phu HT, Nguyen THD, Hasan H, Halabi S, Abdelhady S, Nasrallah GK, Eid AH, Pintus G. Herbal Medicine for Cardiovascular Diseases: Efficacy, Mechanisms, and Safety. Front in Pharmacol 2020; 11
  • 6 Mohammadhosseini M, Frezza C, Venditti A, Mahdavi B. An overview of the genus Aloysia Paláu (Verbenaceae): Essential oil composition, ethnobotany and biological activities. Nat Prod Res 2022; 36: 5091-5107 DOI: 10.1080/14786419.2021.1907576.
  • 7 Coelho FC, Tirloni CAS, Marques AAM, Gasparotto FM, Lívero FAdosR, Gasparotto Junior A. Traditional Plants Used by Remaining Healers from the Region of Grande Dourados, Mato Grosso do Sul. J Relig Health 2019; 58: 572-588 DOI: 10.1007/s10943-018-0713-0.
  • 8 Hellión-Ibarrola MC, Ibarrola DA, Montalbetti Y, Kennedy ML, Heinichen O, Campuzano M, Ferro EA, Alvarenga N, Tortoriello J, De Lima TCM, Mora S. The antidepressant-like effects of Aloysia polystachya (Griseb) Moldenke (Verbenaceae) in mice. Phytomed 2008; 15: 478-483 DOI: 10.1016/j.phymed.2007.11.018.
  • 9 Moller AC, Parra C, Said B, Werner E, Flores S, Villena J, Russo A, Caro N, Montenegro I, Madrid A. Antioxidant and Anti-Proliferative Activity of Essential Oil and Main Components from Leaves of Aloysia polystachya Harvested in Central Chile. Molecules 2020; 26: 131 DOI: 10.3390/molecules26010131.
  • 10 Marchetti L, Pellati F, Graziosi R, Brighenti V, Pinetti D, Bertelli D. Identification and determination of bioactive phenylpropanoid glycosides of Aloysia polystachya (Griseb et Moldenke) by HPLC-MS. J Pharm Biomed Anal 2019; 166: 364-370 DOI: 10.1016/j.pba.2019.01.033.
  • 11 Marques AAM, Lorençone BR, Romão PVM, Guarnier LP, Palozi RAC, Moreno KGT, Tirloni CAS, dos Santos AC, Souza RIC, Klider LM, Lourenço ELB, Tolouei SEL, Budel JM, Khan SI, Silva DB, Gasparotto Junior A. Ethnopharmacological investigation of the cardiovascular effects of the ethanol-soluble fraction of Aloysia polystachya (Griseb) Moldenke leaves in spontaneously hypertensive rats. J Ethnopharmacol 2021; 274: 114077 DOI: 10.1016/j.jep.2021.114077.
  • 12 Aguado MI, Nuñez MB, Bela AJ, Okulik NB, Bregni C. Caracterización fisicoquímica y actividad antioxidante de un extracto etanólico de Aloysia polystachya (Griseb) Mold (Verbenaceae). Rev Mex Cienc Farm 2013; 44: 46-51
  • 13 Aguado MI, Dudik NH, Zamora CMP, Torres CA, Nunez MB. Antioxidant and antibacterial activities of hydroalcoholic extracts from Aloysia polystachya Griseb Moldenke and Lippia turbinata Griseb (verbenaceae). Int J Pharm Pharm Sci 2016; 393-395
  • 14 Pérez-Zamora C, Torres C, Aguado M, Bela A, Nuñez MB, Bregni C. Antibacterial activity of essential oils of Aloysia polystachya and Lippia turbinata (Verbenaceae). Lat Ame and Caribb Bull Med and Arom Plants 2016; 15: 199-215
  • 15 Carmona F, Coneglian FS, Batista PA, Aragon DC, Angelucci MA, Martinez EZ, Pereira AMS. Aloysia polystachya (Griseb) Moldenke (Verbenaceae) powdered leaves are effective in treating anxiety symptoms: A phase-2, randomized, placebo-controlled clinical trial. J Ethnopharmacol 2019; 242: 112060 DOI: 10.1016/j.jep.2019.112060.
  • 16 Mora S, Díaz-Véliz G, Millán R, Lungenstrass H, Quirós S, Coto-Morales T, Hellión-Ibarrola MC. Anxiolytic and antidepressant-like effects of the hydroalcoholic extract from Aloysia polystachya in rats. Pharmacol Biochem Behav 2005; 82: 373-378 DOI: 10.1016/j.pbb.2005.09.007.
  • 17 Moreno KGT, de Almeida TL, Marques AAM, Donadel G, Lourenço ELB, de Almeida D AT, Gasparotto A. Evidence of the Cardioprotective Effects of Aloysia polystachya in Isoproterenol-Induced Myocardial Infarction in Rats. J Med Food 2023; 26: 36-39 DOI: 10.1089/jmf.2022.0027.
  • 18 Jing L, Zhang Y, Fan S, Gu M, Guan Y, Lu X, Huang C, Zhou Z. Preventive and ameliorating effects of citrus D-limonene on dyslipidemia and hyperglycemia in mice with high-fat diet-induced obesity. Eur J Pharmacol 2013; 715: 46-55 DOI: 10.1016/j.ejphar.2013.06.022.
  • 19 Moreno KGT, Marques AAM, da Silva GP, Lourençone BR, Fortini CS, Leite PRT, Dos Santos AC, Souza RIC, da Siva LI, Gasparotto Junior A. A New Approach for the Development of Multiple Cardiovascular Risk Factors in Two Rat Models of Hypertension. Pharmaceuticals (Basel) 2022; 15: 853 DOI: 10.3390/ph15070853.
  • 20 Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Cheng S, Delling FN, Elkind MSV, Evenson KR, Ferguson JF, Gupta DK, Khan SS, Kissela BM, Knutson KL, Lee CD, Lewis TT, Liu J, Loop MS, Lutsey PL, Ma J, Mackey J, Martin SS, Matchar DB, Mussolino ME, Navaneethan SD, Perak AM, Roth GA, Samad Z, Satou GM, Schroeder EB, Shah SH, Shay CM, Stokes A, VanWagner LB, Wang N-Y, Tsao CW. Heart Disease and Stroke Statistics–2021 Update. Circulation 2021; 143: e254 DOI: 10.1161/CIR.0000000000000950.
  • 21 Hurtubise J, McLellan K, Durr K, Onasanya O, Nwabuko D, Ndisang JF. The Different Facets of Dyslipidemia and Hypertension in Atherosclerosis. Curr Atheroscler Rep 2016; 18: 82 DOI: 10.1007/s11883-016-0632-z.
  • 22 Sue LY, Leung AM. Levothyroxine for the Treatment of Subclinical Hypothyroidism and Cardiovascular Disease. Front Endocrinol (Lausanne) 2020; 11: 591588 DOI: 10.3389/fendo.2020.591588.
  • 23 Weber C, Noels H. Atherosclerosis: current pathogenesis and therapeutic options. Nat Med 2011; 17: 1410-1422 DOI: 10.1038/nm.2538.
  • 24 Livero FADR, Gasparotto Junior A. Non-genetic rats models for atherosclerosis research: from past to present. Front Biosci (Schol Ed) 2019; 11: 203-213 DOI: 10.2741/S535.
  • 25 Caesar LK, Cech NB. Synergy and antagonism in natural product extracts: when 1 + 1 does not equal 2. Nat Prod Rep 2019; 36: 869-888 DOI: 10.1039/c9np00011a.
  • 26 Budel JM, Wang M, Raman V, Zhao J, Khan SI, Rehman JU, Techen N, Tekwani B, Monteiro LM, Heiden G, Takeda IJM, Farago PV, Khan IA. Essential Oils of Five Baccharis Species: Investigations on the Chemical Composition and Biological Activities. Molecules 2018; 23: 2620 DOI: 10.3390/molecules23102620.
  • 27 Justus B, Almeida VP de Gonçalves MM, Assunção DPdaSFde, Borsato DM, Arana AFM, Maia BHLNS, Paula JdeFP de. Budel JM, Farago PV. Chemical Composition and Biological Activities of The Essential Oil And Anatomical Markers Of Lavandula Dentata L Cultivated In Brazil. Braz arch biol technol 2018; 61: e18180111 DOI: 10.1590/1678-4324-2018180111.
  • 28 Adams RP. Identification of essential oil components by gas chromatography/mass spectrometry. Ilinois: Allure Publishing Corporation; 1995
  • 29 Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm 2016; 7: 27-31 DOI: 10.4103/0976-0105.177703.
  • 30 Patel M, Mishra V, Pawar V, Ranvir R, Sundar R, Dabhi R. Evaluation of acute physiological and molecular alterations in surgically developed hypothyroid Wistar rats. J Pharmacol Pharmacother 2013; 4: 110-115 DOI: 10.4103/0976-500X.110891.
  • 31 Guarnier LP, Romão PVM, Palozi RAC, Silva AO, Lorençone BR, Marques AAM, dos Santos AC, Souza RIC, Souza KD, Lourenço ELB, Gasparotto Junior A. Development of a Predictive Model to Induce Atherogenesis and Hepato-Renal Impairment in Female Rats. Biomolecules 2019; 9: 664 DOI: 10.3390/biom9110664.
  • 32 Romão PVM, Palozi RAC, Guarnier LP, Silva AO, Lorençone BR, Nocchi SR, Moura C CdeFS. Lourenço ELB, Silva DB, Gasparotto Junior A. Cardioprotective effects of Plinia cauliflora (Mart) Kausel in a rabbit model of doxorubicin-induced heart failure. J Ethnopharmacol 2019; 242: 112042 DOI: 10.1016/j.jep.2019.112042.
  • 33 Gasparotto Jr A, Boffo MA, Lourenço ELB, Stefanello MEA, Kassuya CAL, Marques MCA. Natriuretic and diuretic effects of Tropaeolum majus (Tropaeolaceae) in rats. J Ethnopharmacol 2009; 122: 517-522 DOI: 10.1016/j.jep.2009.01.021.
  • 34 Mcgregor DD. The Effect of Sympathetic Nerve Stimulation of Vasoconstrictor Responses in Perfused Mesenteric Blood Vessels of The Rat. J Physiol 1965; 177: 21-30 DOI: 10.1113/jphysiol.1965.sp007572.